Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

SNP variations in IL10, TNFα and TNFAIP3 genes in patients with dry eye syndrome and Sjogren's syndrome.

Ben-Eli H, Gomel N, Aframian DJ, Abu-Seir R, Perlman R, Ben-Chetrit E, Mevorach D, Kleinstern G, Paltiel O, Solomon A.

J Inflamm (Lond). 2019 Mar 18;16:6. doi: 10.1186/s12950-019-0209-z. eCollection 2019.

2.

Affiliative zygomatic synchrony in co-present strangers.

Golland Y, Mevorach D, Levit-Binnun N.

Sci Rep. 2019 Feb 28;9(1):3120. doi: 10.1038/s41598-019-40060-4.

3.

Shared Medical and Environmental Risk Factors in Dry Eye Syndrome, Sjogren's Syndrome, and B-Cell Non-Hodgkin Lymphoma: A Case-Control Study.

Ben-Eli H, Aframian DJ, Ben-Chetrit E, Mevorach D, Kleinstern G, Paltiel O, Solomon A.

J Immunol Res. 2019 Jan 21;2019:9060842. doi: 10.1155/2019/9060842. eCollection 2019.

4.

Early onset, non-rheumatic, group A streptococcal-associated myocarditis.

Shamriz O, Tal Y, Durst R, Pollak A, Moses AE, Mevorach D.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):546-551. Epub 2019 Jan 3.

PMID:
30620277
5.

Molecular pathogenesis of human CD59 deficiency.

Karbian N, Eshed-Eisenbach Y, Tabib A, Hoizman H, Morgan BP, Schueler-Furman O, Peles E, Mevorach D.

Neurol Genet. 2018 Oct 26;4(6):e280. doi: 10.1212/NXG.0000000000000280. eCollection 2018 Dec.

6.

Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.

Kurolap A, Eshach Adiv O, Hershkovitz T, Tabib A, Karbian N, Paperna T, Mory A, Vachyan A, Slijper N, Steinberg R, Zohar Y, Mevorach D, Baris Feldman H.

J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):325-333. doi: 10.1097/MPG.0000000000002198.

PMID:
30418410
7.

Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.

Tabib A, Hindi I, Karbian N, Zelig O, Falach B, Mevorach D.

Thromb Res. 2018 Aug;168:67-77. doi: 10.1016/j.thromres.2018.06.006. Epub 2018 Jun 11.

PMID:
29929138
8.

[TO BE A RESIDENT IN THE DEPARTMENT OF MEDICINE].

Fischer M, Abu Ghosh Z, Rubin L, Kharouf F, Ayalon O, Dror D, Falah B, Mevorach D.

Harefuah. 2018 Mar;157(3):192-196. Hebrew.

PMID:
29582953
9.

[THE NEW HADASSAH-HEBREW UNIVERSITY MEDICAL CENTER: A LEADER IN ISRAELI PUBLIC MEDICINE].

Mevorach D, Leibergall M, Rothstein Z.

Harefuah. 2018 Mar;157(3):142-144. Hebrew.

PMID:
29582941
10.

Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells.

Trahtemberg U, Mevorach D.

Front Immunol. 2017 Oct 25;8:1356. doi: 10.3389/fimmu.2017.01356. eCollection 2017. Review.

11.

Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy.

Kurolap A, Eshach-Adiv O, Hershkovitz T, Paperna T, Mory A, Oz-Levi D, Zohar Y, Mandel H, Chezar J, Azoulay D, Peleg S, Half EE, Yahalom V, Finkel L, Weissbrod O, Geiger D, Tabib A, Shaoul R, Magen D, Bonstein L, Mevorach D, Baris HN.

N Engl J Med. 2017 Jul 6;377(1):87-89. doi: 10.1056/NEJMc1707173. Epub 2017 Jun 28. No abstract available.

PMID:
28657861
12.

Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations.

Tabib A, Karbian N, Mevorach D.

Mol Immunol. 2017 Sep;89:69-72. doi: 10.1016/j.molimm.2017.05.024. Epub 2017 Jun 13. Review.

PMID:
28622911
13.

Identification and Characterization of Two Human Monocyte-Derived Dendritic Cell Subpopulations with Different Functions in Dying Cell Clearance and Different Patterns of Cell Death.

Trahtemberg U, Grau A, Tabib A, Atallah M, Krispin A, Mevorach D.

PLoS One. 2016 Sep 30;11(9):e0162984. doi: 10.1371/journal.pone.0162984. eCollection 2016.

14.

Medical education in Israel 2016: five medical schools in a period of transition.

Reis S, Urkin J, Nave R, Ber R, Ziv A, Karnieli-Miller O, Meitar D, Gilbey P, Mevorach D.

Isr J Health Policy Res. 2016 Sep 15;5:45. doi: 10.1186/s13584-016-0104-5. eCollection 2016.

15.

Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.

Mevorach D, Reiner I, Grau A, Ilan U, Berkun Y, Ta-Shma A, Elpeleg O, Shorer Z, Edvardson S, Tabib A.

Ann Neurol. 2016 Nov;80(5):708-717. doi: 10.1002/ana.24770. Epub 2016 Sep 19.

PMID:
27568864
16.

Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency.

Ben-Zeev B, Tabib A, Nissenkorn A, Garti BZ, Gomori JM, Nass D, Goldshmidt H, Fellig Y, Anikster Y, Nevo Y, Elpeleg O, Mevorach D.

Eur J Paediatr Neurol. 2015 Nov;19(6):688-93. doi: 10.1016/j.ejpn.2015.07.001. Epub 2015 Jul 20.

PMID:
26233519
17.

Apoptotic cells induce NF-κB and inflammasome negative signaling.

Grau A, Tabib A, Grau I, Reiner I, Mevorach D.

PLoS One. 2015 Mar 30;10(3):e0122440. doi: 10.1371/journal.pone.0122440. eCollection 2015.

18.

Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.

Mevorach D.

Mol Immunol. 2015 Sep;67(1):51-5. doi: 10.1016/j.molimm.2015.03.005. Epub 2015 Mar 26. Review.

PMID:
25818314
19.

Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O.

Immunity. 2015 Feb 17;42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. Epub 2015 Feb 10.

20.

Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.

Szalat A, Shahar M, Shpitzen S, Nachmias B, Munter G, Gillis D, Durst R, Mevorach D, Leitersdorf E, Meiner V, Rosen H.

Endocrine. 2015 Mar;48(2):444-53. doi: 10.1007/s12020-014-0370-3. Epub 2014 Aug 5.

PMID:
25091521
21.

[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].

Ablin JN, Amital H, Ehrenfeld M, Aloush V, Elkayam O, Langevitz P, Mevorach D, Mader R, Sachar T, Amital D, Buskila D; Israeli Rheumatology Association.

Harefuah. 2013 Dec;152(12):742-7, 751, 750. Hebrew.

PMID:
24483001
22.

Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.

Gur C, Coppenhagen-Glazer S, Rosenberg S, Yamin R, Enk J, Glasner A, Bar-On Y, Fleissig O, Naor R, Abed J, Mevorach D, Granot Z, Bachrach G, Mandelboim O.

Cell Host Microbe. 2013 Dec 11;14(6):664-74. doi: 10.1016/j.chom.2013.11.004.

23.

VPS 45-associated primary infantile myelofibrosis--successful treatment with hematopoietic stem cell transplantation.

Stepensky P, Simanovsky N, Averbuch D, Gross M, Yanir A, Mevorach D, Elpeleg O, Weintraub M.

Pediatr Transplant. 2013 Dec;17(8):820-5. doi: 10.1111/petr.12169.

PMID:
24164830
24.

Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.

Mevorach D, Zuckerman T, Reiner I, Shimoni A, Samuel S, Nagler A, Rowe JM, Or R.

Biol Blood Marrow Transplant. 2014 Jan;20(1):58-65. doi: 10.1016/j.bbmt.2013.10.010. Epub 2013 Oct 15.

25.

The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy.

Stepensky P, Saada A, Cowan M, Tabib A, Fischer U, Berkun Y, Saleh H, Simanovsky N, Kogot-Levin A, Weintraub M, Ganaiem H, Shaag A, Zenvirt S, Borkhardt A, Elpeleg O, Bryant NJ, Mevorach D.

Blood. 2013 Jun 20;121(25):5078-87. doi: 10.1182/blood-2012-12-475566. Epub 2013 Apr 18.

26.

CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.

Nevo Y, Ben-Zeev B, Tabib A, Straussberg R, Anikster Y, Shorer Z, Fattal-Valevski A, Ta-Shma A, Aharoni S, Rabie M, Zenvirt S, Goldshmidt H, Fellig Y, Shaag A, Mevorach D, Elpeleg O.

Blood. 2013 Jan 3;121(1):129-35. doi: 10.1182/blood-2012-07-441857. Epub 2012 Nov 13.

27.

Pulmonary hemorrhage in antiphospholipid antibody syndrome.

Scheiman Elazary A, Cohen MJ, Aamar S, Dranitzki Z, Tayer-Shifman O, Mevorach D, Ben-Chetrit E, Naparstek Y.

J Rheumatol. 2012 Aug;39(8):1628-31. doi: 10.3899/jrheum.120205. Epub 2012 Jul 1.

PMID:
22753647
28.

Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice.

Benhamron S, Reiner I, Zcharia E, Atallah M, Grau A, Vlodavsky I, Mevorach D.

PLoS One. 2012;7(5):e35602. doi: 10.1371/journal.pone.0035602. Epub 2012 May 10.

29.

Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway.

Atallah M, Krispin A, Trahtemberg U, Ben-Hamron S, Grau A, Verbovetski I, Mevorach D.

PLoS One. 2012;7(2):e29333. doi: 10.1371/journal.pone.0029333. Epub 2012 Feb 17.

30.

Paradoxical response in ocular bartonellosis.

Zimran E, Shilo S, Florescu T, Dotan S, Balag S, Mevorach D, Shibolet O, Amer R.

J Ophthalmic Inflamm Infect. 2012 Mar;2(1):53-6. doi: 10.1007/s12348-011-0046-6. Epub 2011 Nov 5. No abstract available.

31.

Role of class A human thrombospondins in the clearance of dying cells and tolerance induction.

Tabib A, Krispin A, Mevorach D.

Ann N Y Acad Sci. 2010 Oct;1209:43-8. doi: 10.1111/j.1749-6632.2010.05773.x.

PMID:
20958315
32.

What do we mean when we write "senescence," "apoptosis," "necrosis," or "clearance of dying cells"?

Mevorach D, Trahtemberg U, Krispin A, Attalah M, Zazoun J, Tabib A, Grau A, Verbovetski-Reiner I.

Ann N Y Acad Sci. 2010 Oct;1209:1-9. doi: 10.1111/j.1749-6632.2010.05774.x.

PMID:
20958309
33.

The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stress.

Ergaz Z, Mevorach D, Goldzweig G, Cohen A, Patlas N, Yaffe P, Blank M, Shoenfeld Y, Ornoy A.

Lupus. 2010 Dec;19(14):1623-31. doi: 10.1177/0961203310377218. Epub 2010 Sep 2.

PMID:
20813798
34.

Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.

Mevorach D.

Apoptosis. 2010 Sep;15(9):1114-23. doi: 10.1007/s10495-010-0530-8. Review.

PMID:
20683667
35.

An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR.

Immunology. 2010 Jul;130(3):337-43. doi: 10.1111/j.1365-2567.2010.03245.x. Epub 2010 Feb 26.

36.

iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade.

Amarilyo G, Verbovetski I, Atallah M, Grau A, Wiser G, Gil O, Ben-Neriah Y, Mevorach D.

Eur J Immunol. 2010 Mar;40(3):699-709. doi: 10.1002/eji.200838951.

37.

Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells.

Tabib A, Krispin A, Trahtemberg U, Verbovetski I, Lebendiker M, Danieli T, Mevorach D.

PLoS One. 2009 Aug 31;4(8):e6840. doi: 10.1371/journal.pone.0006840.

38.

Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.

Mevorach D, Elchalal U, Rein AJ.

Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Review.

PMID:
19584727
39.

Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.

Rein AJ, Mevorach D, Perles Z, Gavri S, Nadjari M, Nir A, Elchalal U.

Circulation. 2009 Apr 14;119(14):1867-72. doi: 10.1161/CIRCULATIONAHA.108.773143. Epub 2009 Mar 30.

PMID:
19332471
40.

Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus.

Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D.

Eur J Immunol. 2008 Oct;38(10):2896-904. doi: 10.1002/eji.200838342.

41.

Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience.

Hershko AY, Berkun Y, Mevorach D, Rubinow A, Naparstek Y.

Semin Arthritis Rheum. 2008 Oct;38(2):110-5. doi: 10.1016/j.semarthrit.2007.09.007. Epub 2008 Jan 25.

PMID:
18221986
42.

'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells.

Zaguri R, Verbovetski I, Atallah M, Trahtemberg U, Krispin A, Nahari E, Leitersdorf E, Mevorach D.

Clin Exp Immunol. 2007 Sep;149(3):543-52. Epub 2007 Jul 23.

43.

Calcium, leukocyte cell death and the use of annexin V: fatal encounters.

Trahtemberg U, Atallah M, Krispin A, Verbovetski I, Mevorach D.

Apoptosis. 2007 Oct;12(10):1769-80.

PMID:
17578666
44.

Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus.

Uziel Y, Gorodnitski N, Mukamel M, Padeh S, Brik R, Barash J, Mevorach D, Berkun Y, Tauber T, Press J, Harel L, Navon P, Rubenstein M, Naparstek Y, Hashkes PJ; Pediatric Rheumatology Study Group Of Israel @ SLERI.

Lupus. 2007;16(2):142-6.

PMID:
17402372
45.

Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS.

Schwartz N, Shoenfeld Y, Barzilai O, Cervera R, Font J, Blank M, Yacobi S, Patlas N, Cohen A, Mevorach D, Ornoy A.

Lupus. 2007;16(2):110-20.

PMID:
17402367
46.

Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages.

Tassiulas I, Park-Min KH, Hu Y, Kellerman L, Mevorach D, Ivashkiv LB.

Hum Immunol. 2007 Mar;68(3):156-64. Epub 2007 Jan 8.

47.

Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states.

Krispin A, Bledi Y, Atallah M, Trahtemberg U, Verbovetski I, Nahari E, Zelig O, Linial M, Mevorach D.

Blood. 2006 Nov 15;108(10):3580-9. Epub 2006 Aug 1.

48.

Spontaneous rupture of lung echinococcal cyst causing anaphylactic shock and respiratory distress syndrome.

Fanne RA, Khamaisi M, Mevorach D, Leitersdorf E, Berkman N, Laxer U, Maly B.

Thorax. 2006 Jun;61(6):550. No abstract available.

49.

Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.

Benhamron S, Nechushtan H, Verbovetski I, Krispin A, Abboud-Jarrous G, Zcharia E, Edovitsky E, Nahari E, Peretz T, Vlodavsky I, Mevorach D.

J Immunol. 2006 Jun 1;176(11):6417-24.

50.

Clozapine-induced systemic lupus erythematosus.

Rami AF, Barkan D, Mevorach D, Leitersdorf E, Caraco Y.

Ann Pharmacother. 2006 May;40(5):983-5. Epub 2006 May 2.

PMID:
16670363

Supplemental Content

Loading ...
Support Center